PHARMOSA BIOPHARM INC financial statements, including revenue, expenses, profit, and loss

The total revenue of 6875 for the last quarter is 9.54 M TWD, and it's 12622.67% higher compared to the previous quarter. The net income of Q2 24 is -58.61 M TWD.